Sir Jonathan Van-Tam joins 5654 & Company as Senior Advisor
Sir Jonathan Van-Tam will work across the Health & Life Sciences client portfolio as it grows Sir Jonathan previously served as Deputy Chief Medical Officer to HM Government from 2017 to 2022 and was ...
Cosmetics Business16h
L’Oréal sells €3 billion of Sanofi stock back to pharmaceutical group
The beauty giant said the transaction – selling approximately 29.6 million of its Sanofi shares for €101.5 per share – will ...
The Pharma Letter13h
Russia to significantly expand geography of its drug export
Russia plans to significantly expand the geography of the export of its drugs this year, paying attention both to emerging ...
The Pharma Letter17h
Sweden’s annual life science conference highlights need for action
At Sweden’s annual life science conference, stakeholders from healthcare, academia, and industry discussed implementing the ...
GlobalData on MSN16h
Sanofi’s Sarclisa combo approved in China for multiple myeloma
Sanofi has received China’s National Medical Products Administration (NMPA) approval for the use of Sarclisa (isatuximab), ...
NJBIZ18h
Restaurateur reimagining what space works best in hybrid-work era
After nearly three decades in Morristown, Mehtani Restaurant Group is planning a new concept that caters to post-pandemic ...
Sanofi: Sanofi announces buy back of shares from L'Oréal
Sanofi announces buy back of shares from L'Oréal Paris, February 3, 2025. Sanofi today announces the acquisition of 2.3% of its shares from long-standing shareholder L'Oréal. This transaction is part ...
EuropaWire13h
Sanofi Acquires 2.3% of Shares from L’Oréal as Part of Ongoing Buyback Program
Sanofi has announced the acquisition of 2.3% of its shares from L’Oréal, a long-standing shareholder, as part of its ongoing share buyback pro ...